Recent Posts
- Tenpoint Therapeutics Ltd. Announces FDA Acceptance of New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia
- Augustine Therapeutics announces first patient dosed in Phase I for the treatment of Charcot-Marie-Tooth disease
- SparingVision Presents PRODYGY data and Research Update in Two Oral Presentations at ASGCT 2025
- Astraveus Enters Strategic Partnership with NecstGen to evaluate Lakhesys Benchtop Cell FactoryTM for CAR-T therapy manufacturing
- Tenpoint Therapeutics Ltd. Submits New Drug Application to U.S. FDA for BRIMOCHOLTM PF for the Treatment of Presbyopia